The link between excitotoxic oligodendroglial death and demyelinating diseases

Trends in Neurosciences

Volumn 24, Issue 4, 2001, Pages 224-230

  Matute, Carlos ^a   Alberdi, Elena ^a   Domercq, María ^a   Pérez Cerdá, Fernando ^a   Pérez Samartín, Alberto ^a   Sánchez Gómez, María Victoria ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; GLUTAMATE RECEPTOR; GLUTAMIC ACID; KAINIC ACID;

CALCIUM HOMEOSTASIS; CELL DEATH; DEMYELINATING DISEASE; HISTOPATHOLOGY; NERVE DEGENERATION; NERVE EXCITABILITY; NONHUMAN; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; AUTOIMMUNITY; CELL DEATH; DEMYELINATING DISEASES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GLUTAMIC ACID; HUMANS; MULTIPLE SCLEROSIS; NEUROTOXINS; OLIGODENDROGLIA; OPTIC NERVE; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID;

EID: 0035313969     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(00)01746-X     Document Type: Review

References (63)

1. The toxic effect of sodium L-glutamate on the inner layers of the retina
2. Brain lesions in an infant rhesus monkey treated with monosodium glutamate
3. Glutamate neurotoxicity and diseases of the nervous system
4. Excitatory amino acids as a final common pathway for neurologic disorders
5. The changing landscape of ischaemic brain injury mechanisms
6. Tripartite synapses: Glia, the unacknowledged partner
7. Glutamatergic synapses on oligodendrocyte precursor cells in hippocampus
8. Glutamate receptors in glia: New cells, new inputs and new functions
9. Pathophysiology of oligodendroglial excitotoxicity
10. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes
11. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity
12. On how altered glutamate homeostasis may contribute to demyelinating diseases of the CNS
13. Glutamate excitotoxicity in a model of multiple sclerosis
14. Autoimmune encephalomyelitis ameliorated by AMPA antagonists
15. Demyelinating diseases
16. Progress in determining the causes and treatment of multiple sclerosis
17. Molecular biology of glutamate receptors in the Central Nervous System and their role in excitotoxicity, oxidative stress and aging
18. Cloned glutamate receptors
19. The glutamate receptor ion channels
20. Kainate receptors
21. Gamma-aminobutyric acid and glutamate receptors
22. News on glutamate receptors in glial cells
23. Astrocytic neurotransmitter receptors in situ and in vivo
24. Ion channels in glial cells
25. Expression of ionotropic glutamate receptor subunits in glial cells of the hippocampal CA1 area following transient forebrain ischemia
26. AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia
27. Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptor
28. AMPA and kainate receptors each mediate excitotoxicity in oligodendrocyte cultures
29. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter
30. Calcium permeability of glutamate gated channels in the central nervous system
31. Selective RNA editing and subunit assembly of native glutamate receptors
32. Reduced editing of low affinity kainate receptor subunits in optic nerve glial cells
33. Shapping excitation at glutamatergic synapses
34. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate
35. Calcium signaling of glial cells along mammalian axons
36. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes
37. Selective uptake of neuroactive amino acids by both oligodendrocytes and astrocytes in primary dissociated culture: A possible role for oligodendrocytes in neurotransmitter metabolism
38. Expression of glutamate transporters in rat optic nerve oligodendrocytes
39. +-dependent glutamate transport
40. Properties of acute and chronic kainate excitotoxic damage to the optic nerve
41. Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage
42. Oligodendrocytes and microglia are selectively vulnerable to combined hypoxia and hypoglucemia injury in vitro
43. Rapid ischemic cell death in immature oligodendrocytes: A fatal glutamate release feedback loop
44. Glutamate release in severe brain ischaemia is mainly by reversed uptake
45. Ischemic damage and subsequent proliferation of oligodendrocytes in focal cerebral ischemia
46. Perinatal neuropathology
47. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion
48. Axonal transection in the lesions of multiple sclerosis
49. Endogenous progenitors remyelinate demyelinated axons of the adult CNS
50. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
51. Assessment of animal models for MS and demyelinating disease in the design of rational therapy
52. Experimental models of multiple sclerosis
53. Excitotoxic insults to the optic nerve cause alterations in cortical evoked potentials
54. The development of Cop1 (Copaxone®), an innovative drug for the treatment of multiple sclerosis: Personal reflections
55. Neurotransmitters in cerebrospinal fluid reflect pathological activity
56. Changes in neurotransmitters in multiple sclerosis
57. Murine macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate
58. Glutamate release from microglia via glutamate transporter is enhanced by amyloid-β peptide
59. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes
60. Demyelination: The role of reactive oxygen and nitrogen species
61. Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for the pathogenesis of HIV-1 dementia
62. Molecular neurobiology and genetics: Investigation of neural function and dysfunction